Skip to content

Study of the efficacy of topically applied cyclosporinsolution on psoriatic nails.

Study of the efficacy of topically applied cyclosporinsolution on psoriatic nails.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON25326
Enrollment
40
Registered
2006-06-23
Start date
2006-07-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis of the vingernails.

Interventions

On left and right vingernails either placebo, either 100mg/ml ciclosporin application, twice daily. The duration of the treatment is till complete cure or for a maximum of 16 weeks. Control group ma

Sponsors

Erasmus MC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Clinical diagnosis of psoriasis of fingernails in both hands; 2. In cases of oral treatment with methotrexate, prednisone or fumarates, the dose of medication before the start has to be constant for 8 weeks and it may be reasonably expected that the dose shall not be altered during the treatment phase of the study; 3. A minimum of at least 2 affected nails on the left hand and the right hand, and the number of affected nails may differ by 1 nail at the maximum on the left hand compared with those on the right hand.

Exclusion criteria

Exclusion criteria: 1. Systemic treatment with cyclosporine or a biological agent (efaluzimab, etanercept or related medication); 2. Change of oral medication 8 weeks before the start of the trial; 3. Pregnancy.

Design outcomes

Primary

MeasureTime frame
NAPSI scores.

Secondary

MeasureTime frame
Prevention? Does the NAPSI correlate with patientsatisfaction?

Contacts

Public ContactAnnik Rengen, van

Erasmus Medical Center Rotterdam, Dr. Molewaterplein 40, P.O. Box 2040

a.vanrengen@erasmusmc.nl+31 (0)10 4634569

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)